Life Sciences
Our nationally recognized life sciences lawyers handle complex matters of crucial importance to our clients.
Pharmaceuticals
For more than three decades, Orrick lawyers have represented some of the world’s largest manufacturers of branded prescription drugs in a wide range of complex commercial, intellectual property and product liability litigation. Our experience includes defending major pharmaceutical companies in industry-wide litigation concerning pricing practices, lawsuits related to drug distribution, patent infringement claims and antitrust issues that stem from those claims, and, of course, product liability cases. From start-ups to large multinational public corporations, Orrick also works with many scientists and entrepreneurs to form companies, identify early-stage funding sources and negotiate private financing rounds to fuel initial growth.
Medical Devices
Orrick assists medical device clients with a broad range of services, including financing, domestic and international patent counseling, licensing and partnering, mergers and acquisitions, and patent and products liability litigation. We closely monitor the evolving regulation of the industry, and we provide valuable international connections through our offices in Europe and Asia. Our clients in this sector include manufacturers of cardiac pacemakers, coronary stents, ultrasound imagers, digital dentistry, optical lenses, breast implants, spinal implants, surgical instruments, microcoils for brain aneurysms, single-use injection systems, laser systems and non-invasive pulse oximeters.
Practice Highlights
Orrick’s global Antitrust and Competition Group is at the forefront of critical antitrust and competition issues. In addition to our vast litigation experience, we regularly counsel clients in the life sciences industry on matters such as dominant firm conduct, mergers and acquisitions, joint ventures, international investigations, distribution restrictions and intellectual property licensing. Our work includes strategic advice to drug makers and distributors on pricing strategies, dealing with hospitals and managed care organizations and various competition agencies.
Our corporate team represents life sciences companies at all phases of development from early stage to publicly-traded. We represent licensors, licensees, developers, investors in new technology, large technology companies, sellers and purchasers of new and existing technology, vendors and buyers of content, inventors and emerging technology companies—helping all parties to a transaction understand each other’s strategic interests. Clients enlist us to craft the full range of commercial and partnering arrangements, including agreements to develop, license, test, market, manufacture, supply, distribute, co-brand, advertise, protect and acquire or divest technology, products, medical devices, pharmaceutical products, Internet properties, digital content and related intellectual property rights.
Our relationships with more than 100 venture capital firms assist clients in securing crucial financing. Work for established companies includes public offerings, mergers and acquisitions and corporate governance. We negotiate crucial strategic alliances and collaboration deals, including numerous international licensing agreements, and we also advise on the securitization of royalty payments.
Our intellectual property litigators are widely recognized for trial and appellate successes. We have delivered exceptional results for major pharmaceutical companies in courts across the United States for three decades. Our deep bench of first-chair IP lawyers has demonstrable technical depth in patent applications, with more than half of our IP litigators admitted to practice before the U.S. Patent and Trademark Office. We closely monitor the evolving jurisprudence regarding gene patents and we are prepared to defend false advertising claims brought under the Lanham Act.
Orrick’s trial-seasoned product liability lawyers successfully defend clients in major class actions, mass torts and other complex litigation in courtrooms around the country. Our work covers a broad range of companies and products, including pharmaceuticals, vaccines and biologics, medical devices, nutritional and dietary supplements, and consumer personal care products.
Orrick's product liability practice was recognized among the leading practices in the United States by Chambers USA: America's Leading Lawyers for Business 2011. Chambers has applauded our product liability team for its "impressive technical knowledge of scientific and medical issues, which regularly includes developing both pretrial and trial strategies around causation."
 Top
|
web-friendly